Loading…
Reported covered position: Legislative Assistant, Rep. John Tierney; Legislative Correspondent, Sen. Tom Carper.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE UNITED STATES PHARMACOPEIAL CONVENTION via THE UNITED STATES PHARMACOPEIAL CONVENTION
2026 · third_quarter · Q3
H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain. Issues related to questions for the record (QFRs) for Administration for Strategic Preparedness and Response and Food and Drug Administration nominees.
Source: Senate LDA
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act - Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain. Issues related to questions for the record (QFRs) for Administration for Strategic Preparedness and Response and Food and Drug Administration nominees.
National Security, Department of State, and Related Programs Appropriations Act, 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
National Security, Department of State, and Related Programs Appropriations Act, 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
National Defense Authorization Act for Fiscal Year 2027
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 2296 - National Defense Authorization Act for Fiscal Year 2026; H.R. 8800 - National Defense Authorization Act for Fiscal Year 2027: Provisions related to supply chain resilience.
National Defense Authorization Act for Fiscal Year 2027
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 2296 - National Defense Authorization Act for Fiscal Year 2026; H.R. 8800 - National Defense Authorization Act for Fiscal Year 2027: Provisions related to supply chain resilience.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain. Issues related to questions for the record (QFRs) for Administration for Strategic Preparedness and Response and Food and Drug Administration nominees.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act - Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain.
National Defense Authorization Act for Fiscal Year 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 2296 - National Defense Authorization Act for Fiscal Year 2026; H.R. 8800 - National Defense Authorization Act for Fiscal Year 2027: Provisions related to supply chain resilience.
National Defense Authorization Act for Fiscal Year 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 2296 - National Defense Authorization Act for Fiscal Year 2026; H.R. 8800 - National Defense Authorization Act for Fiscal Year 2027: Provisions related to supply chain resilience.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
CLEAR LABELS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.
CLEAR LABELS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act - Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain.
CLEAR LABELS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain. Issues related to questions for the record (QFRs) for Administration for Strategic Preparedness and Response and Food and Drug Administration nominees.
CLEAR LABELS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain resilience. Issues regarding drug shortages and pharmaceutical supply chain resilience.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain resilience. Issues regarding drug shortages and pharmaceutical supply chain resilience.
National Security, Department of State, and Related Programs Appropriations Act, 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
H.R. 5304, S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 4779 National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
H.R. 5304, S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
H.R. 5304, S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 4779 National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain resilience. Issues regarding drug shortages and pharmaceutical supply chain resilience.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages.
MAPS Act
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain resilience. Issues regarding drug shortages and pharmaceutical supply chain resilience.
National Defense Authorization Act for Fiscal Year 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 2296 - National Defense Authorization Act for Fiscal Year 2026: Provisions regarding medicine supply chain.
National Defense Authorization Act for Fiscal Year 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
S. 2296 - National Defense Authorization Act for Fiscal Year 2026: Provisions regarding medicine supply chain.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
H.R. 5304, S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 4779 National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION
H.R. 5304, S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
S. 2296 - National Defense Authorization Act for Fiscal Year 2026; H.R. 8800 - National Defense Authorization Act for Fiscal Year 2027: Provisions related to supply chain resilience.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
THE UNITED STATES PHARMACOPEIAL CONVENTION via THE UNITED STATES PHARMACOPEIAL CONVENTION
2026 · first_quarter · 1A
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027: Provisions related to Administration for Strategic Preparedness and Response (ASPR) mapping. FY 2027 Commerce, Justice, Science, and Related Agencies Appropriations: Provisions related to 3D-printing. FY 2027 State-Foreign Operations Appropriations: Provisions related to pharmaceutical supply chain resilience.
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE UNITED STATES PHARMACOPEIAL CONVENTION via THE UNITED STATES PHARMACOPEIAL CONVENTION
2026 · second_quarter · Q2
S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act - Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain.
H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
S. 2296 - National Defense Authorization Act for Fiscal Year 2026; H.R. 8800 - National Defense Authorization Act for Fiscal Year 2027: Provisions related to supply chain resilience.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
THE UNITED STATES PHARMACOPEIAL CONVENTION via THE UNITED STATES PHARMACOPEIAL CONVENTION
2026 · first_quarter · Q1
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027: Provisions related to Administration for Strategic Preparedness and Response (ASPR) mapping. FY 2027 Commerce, Justice, Science, and Related Agencies Appropriations: Provisions related to 3D-printing. FY 2027 State-Foreign Operations Appropriations: Provisions related to pharmaceutical supply chain resilience.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE UNITED STATES PHARMACOPEIAL CONVENTION via THE UNITED STATES PHARMACOPEIAL CONVENTION
2025 · fourth_quarter · Q4
H.R. 5304, S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 4779 National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
S. 2296 - National Defense Authorization Act for Fiscal Year 2026: Provisions regarding medicine supply chain.
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE UNITED STATES PHARMACOPEIAL CONVENTION via THE UNITED STATES PHARMACOPEIAL CONVENTION
2025 · third_quarter · Q3
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain resilience. Issues regarding drug shortages and pharmaceutical supply chain resilience.
H.R. 5304, S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.
S. 2296 - National Defense Authorization Act for Fiscal Year 2026: Provisions regarding medicine supply chain.
THE UNITED STATES PHARMACOPEIAL CONVENTION via THE UNITED STATES PHARMACOPEIAL CONVENTION
2025 · second_quarter · Q2
S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain resilience. Issues regarding drug shortages and pharmaceutical supply chain resilience.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE